Skip to main content

Advertisement

Table 3 Results for the FAS after 6 and 12 months (mRS, mortality)

From: The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial

  Placebo Dexamethasone Total p-value
N = 19 N = 19 N = 38
Dichotomized mRS at 6 months
 < = 2 12 (63.2%) 12 (63.2%) 24 (63.2%) 1.0000
 > 2 7 (36.8%) 7 (36.8%) 14 (36.8%)  
Mortality at 6 months
 Alive 18 (100%) 14 (93.3%) 32 (97.0%) 0.2660
 Dead 0 (0)%) 1 (6.7%) 1 (3.1%)  
 Missing 1 4 5  
Dichotomized mRS at 12 months
 < = 2 9 (56.3%) 7 (53,8%) 16 (55.2%) 0.8970
 > 2 7 (43.8%) 6 (46.2%) 13 (44.8%)  
 Missing 3 6 9  
Mortality at 12 months
 Alive 13 (86.7%) 11 (91.7%) 24 (88.9%) 0.6812
 Dead 2 (13.3%) 1 (8.3%) 3 (11.1%)  
 Missing 4 7 11